Skip to content

Gro-alpha and MCP-1 as potential markers for preoperative identification of old patients with hip fractures at risk for developing complications after surgery.

Gro-alpha and MCP-1 as potential markers for preoperative identification of old patients with hip fractures at risk for developing complications after surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000400
Enrollment
80
Registered
2010-05-07
Start date
2010-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip fracture S72.00

Interventions

Group 1: Blood samples of 36 ml blood are taken from patients pre operativey and within 12 hours after surgery. Group 2: A blood sample of 36 ml is taken once from the probands.

Sponsors

Klinikum rechts der Isar, Technische Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to No maximum

Inclusion criteria

Inclusion criteria: inclusion criteria for the patients: -older than 75 years for group 1 and for group 2 older than 18 years and younger than 40 years -informed consent - hip fracture (group1) and fracture of a long bone (group2) respectively inclusion criteria for the probands: - older than 75 years for group 1 and for group 2 older than 18 years and younger than 40 years - informed consent - no fracture within the last twelve weeks

Exclusion criteria

Exclusion criteria: exclusion criteria for the patients and probands - younger than 18 years - pregnancy -open fractures -periprothetic fractures -polytrauma -patients with systemic infection diseases -tumours, radiochemotherapy -intake of drugs which could modulate the immune system like corticosteroids -patients/probands who cannot give their informed consent

Design outcomes

Primary

MeasureTime frame
Expression levels of GRO- alpha and MCP-1 in the serum of patients older than 75 years with a hip fracture and with or without postoperative complications. These expression levels are analysed in the serum of blood sampley taken pre- and postoperatively. Complications are detected during the in-hospital stay of the patients.

Secondary

MeasureTime frame
Analysis of transcription factors (STAT, JNK) in granulocytes and monocytes.

Countries

Germany

Contacts

Public ContactHelen Vester

Klinikum rechts der Isar, Abteilung für Unfallchirurgie, Technische Universität München

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026